RE
Replimune Group, Inc.
REPL · NASDAQ
$12.92 -3.08% (-$0.41)
1M -13.69%
Market Cap $1.11B
P/E Ratio -
Div. Yield -
ROE 159.33%
Bulios Fair Price
$9.71
24.8% downside
Trenutna cena
$12.92
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica REPL trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 10.53x
PEG N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 33.11%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 159.33%
ROA 117.65%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 5.23x
Int. coverage -30.82x
Debt/Equity 0.26x
Stability
78 /100
Stable EPS volatility 8.40%
Profitable years 0
Beta 0.94x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o REPL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sushil Patel
Employees
465
Headquarters
Woburn
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report